- Home
- Equipment
- asia middle east
- clinical program
Refine by
Clinical Program Equipment Supplied In Asia Middle East
8 equipment items found
Manufactured by:Daiichi Sankyo Company Limited based inTokyo, JAPAN
Oral, once-daily, direct factor Xa (pronounced “Ten A”) inhibitor. More than 100,000 patients worldwide are expected to participate in the edoxaban clinical research program, which is comprised of more than 10 RCTs (randomized, controlled trials), non-interventional studies and registries, including completed, ongoing and future research. ...
Manufactured by:Ito Co., Ltd. based inKawaguchi City, Saitama, JAPAN
Electrotherapy Device with 4 Independent Channels and Body Diagram ...
Manufactured by:Ito Co., Ltd. based inKawaguchi City, Saitama, JAPAN
Electrotherapy Device with 2 Independent Channels and Body Diagram ...
Manufactured by:Ito Co., Ltd. based inKawaguchi City, Saitama, JAPAN
High-end Combination Unit with 3 Independent Channels and Body Diagram ...
Manufactured by:Ito Co., Ltd. based inKawaguchi City, Saitama, JAPAN
High-end Combination Unit with 5 Independent Channels and Body Diagram ...
Manufactured by:Medarchitect based in, CHINA
The Medarchitect Suture Practice Arm is ideal for hand surgical suture training. Made of high-quality silicone, this Suturing Training Hand Model features realistic textures—including wrinkles, pores, and visible fingerprints. The skin is soft and elastic for smooth suturing, yet tough enough to resist tearing during repeated ...
Manufactured by:Medical Quant based inKfar-Saba, ISRAEL
Designed principally for Home Healthcare, Handy Cure is a portable medical device for relieving pain and for treating a wide range of aches and inlammations. Handy Cure can be operated for up to 18 hours using a rechargeable lithium battery, so you can treat yourself anywhere, ...
Manufactured by:Minaris Regenerative Medicine, LLC based inAllendale, NEW JERSEY (USA)
Having this team creates the potential to accelerate your progress to market and to both anticipate and overcome your challenges, while reducing the overall cost and risk of your clinical and commercial development programs. ...